UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy
Kanzen said Tuesday that it has signed an agreement with Corea Therapeutics...
by Lee Han-soo
|
2019-01-23 21:29
라인
Philips Korea to increase market share for CPAP with connected care strategy
Phillips Korea aims to expand its market share in the continuous positive a...
by Lee Han-soo
|
2019-01-23 16:21
라인
‘Trade deal with US makes it hard for Seoul to support local drugmakers’
Health and Welfare Minister Park Neung-hoo said he felt frustrated about no...
by Kwak Sung-sun
|
2019-01-23 15:31
라인
Court rejects patent registration for acute myeloid leukemia drug Vyxeos
The Patent Court of Korea has rejected Jazz Pharmaceuticals’ application fo...
by Lee Hye-seon
|
2019-01-23 14:47
라인
Legal work hour limit reduces trainee doctors’ hours of labor
The local law capping the maximum weekly work hours for trainee physicians ...
by Lee Min-ju
|
2019-01-23 11:58
라인
Lilly returns rights for Hanmi’s BTK inhibitor candidate
Hanmi Pharmaceutical said Wednesday that Lilly has returned licensing right...
by Lee Han-soo
|
2019-01-23 10:21
라인
Bridge Biotherapeutics licenses in new targeted thearpy candidate
Bridge Biotherapeutics said Wednesday that it has signed a technology trans...
by Lee Han-soo
|
2019-01-23 10:20
라인
Court suspends FSC’s disciplinary ruling against Samsung BioLogics
The Seoul Administrative Court has suspended the Financial Services Commiss...
by Lee Han-soo
|
2019-01-22 22:30
라인
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has signed an agreement with Chong Kun D...
by Lee Han-soo
|
2019-01-22 16:03
라인
Seoul’s disease control questioned amid spreading fears over measles
Experts are raising concerns that the Korean government’s epidemic preventi...
by Choi Gwang-seok
|
2019-01-22 15:16
라인
‘We Want Healthcare’ introduces Lunit AI to its screening system
Lunit, a medical artificial intelligence (AI) company, said Tuesday that it...
by Lee Han-soo
|
2019-01-22 14:56
라인
‘Appendicitis patients' prognosis remains similar if surgery is done within 24 hours’
If only people with appendicitis get surgery within 24 hours of its breakou...
by Lee Han-soo
|
2019-01-22 14:55
라인
Most training hospitals let unlicensed assistants perform surgeries
Last year, the medical community came under fire for allowing unlicensed as...
by Lee Min-ju
|
2019-01-22 14:53
라인
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’
The Korea Pharmaceutical Distribution Association (KPDA) is seeking to file...
by Park Gi-taek
|
2019-01-22 14:18
라인
BMS, Ono Pharma wins more indication for Opdivo in EU
Bristol-Myers Squibb (BMS) and Ono Pharma Korea have received an additional...
by Lee Han-soo
|
2019-01-21 18:01
라인
New HIV combo pill Biktarvy approved in Korea
Gilead Sciences said it has obtained approval for Biktarvy, a three-in-one ...
by Lee Hye-seon
|
2019-01-21 15:36
라인
JW wins sales go-ahead for hemophilia A treatment
JW Pharmaceutical said Sunday that the Ministry of Food and Drug Safety has...
by Lee Han-soo
|
2019-01-21 15:35
라인
Novo Nordisk increases market share for mixed insulin in Korea
Novo Nordisk Korea said Monday that Ryzodeg, the company’s soluble insulin ...
by Lee Han-soo
|
2019-01-21 14:44
라인
‘Customized therapy for schizophrenia may be possible’
A local study raised the possibility that physicians can pick and choose th...
by Choi Gwang-seok
|
2019-01-21 14:43
라인
Sillajen releases interim results for combination cancer treatment in US
Sillajen said Monday that it has presented the National Cancer Institute’s ...
by Lee Han-soo
|
2019-01-21 14:20
-
이전
151
152
153
154
155
156
157
158
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top